Artbio
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company headquartered in Cambridge, Massachusetts, focused on developing a new class of alpha radioligand therapies (ARTs) for cancer treatment. Founded in 2021 by Roy Larsen and led by CEO Emanuele Ostuni, ARTBIO aims to redefine cancer care by leveraging its proprietary isotope manufacturing technology and collaborations with institutions like Oslo University Hospital. The company has raised $90 million in Series A financing to advance its pipeline and maximize the therapeutic potential of its targeted alpha radioligand therapies.Recent Posts by Artbio
- Senior Clinical Trial ManagerSOMERVILLE, MAPosted 8 days ago•Similar jobs
- Clinical Trial ManagerSOMERVILLE, MAPosted 30+ days ago•Similar jobs
- Office Manager / Lab SupervisorSOMERVILLE, MAPosted 30+ days ago•Similar jobs
- Associate Director, Radiopharmaceutical DevelopmentSOMERVILLE, MAPosted 30+ days ago•Similar jobs
- Clinical and Preclinical Quality DirectorSOMERVILLE, MAPosted 30+ days ago•Similar jobs
- Senior Director, Clinical OperationsSOMERVILLE, MAPosted 30+ days ago•Similar jobs
- Director of Clinical Data ManagementSOMERVILLE, MAPosted 30+ days ago•Similar jobs
- Senior Director, Intellectual PropertySOMERVILLE, MAPosted 30+ days ago•Similar jobs
- Senior Medical Director, Clinical DevelopmentSOMERVILLE, MAPosted 30+ days ago•Similar jobs
- Director/Senior Director, Clinical Imaging (US based)SOMERVILLE, MAPosted 30+ days ago•Similar jobs
1-10 of 10